U.S. federal trademark · Serial No. 97016650
Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or symptoms associated with depression or other central nervous system disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.